PRELUDE CAPITAL MANAGEMENT, LLC - NOVUS THERAPEUTICS INC ownership

NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 1 filers reported holding NOVUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NOVUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$19,00020,2820.00%
Other shareholders
NOVUS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 80,069$1,233,0000.56%
View complete list of NOVUS THERAPEUTICS INC shareholders